GH
GeneDx Holdings Corp.
🇺🇸XNAS.WGSUnited StatesHealthcare
$97.50USDup +2.91 (+3.08%)ClosedDelayed2:47 AM
Price$97.50+2.91 (+3.08%)
Profile
- Healthcare
- Diagnostics & Research
- United States
Identity
- Exchange
- Nasdaq . XNAS
- Type
- Stock
- ISIN
- US81663L2007
- CUSIP
- 81663L200
Company
- Employees
- 1,300
- Headquarters
- Stamford, United States
- Website
- https://www.genedx.com
- CEO
- Ms. Katherine A. Stueland
Market
- Shares outstanding
- 29.8M
- Market cap
- $2.91B
Key dates
- Next earnings
- Oct 27, 2026
Highlights
- Market cap
- $2.82B
- EPS LTM
- -$3.58
- P/E LTM
- -19.29
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $454.43M+25.42%up year on year
- Net income
- -$106.36M-7,664.51%down year on year
- Gross margin
- 68.2%+1.51%up year on year
- Free cash flow
- -$75.8M-9,232.29%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.